Vicarious Surgical Inc.
General ticker "RBOT" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $14.6M (TTM average)
Vicarious Surgical Inc. does not follow the US Stock Market performance with the rate: -24.0%.
Estimated limits based on current volatility of 23.7%: low 0.06$, high 0.10$
Factors to consider:
- Total employees count: 26 (-78.9%) as of 2025
- Top business risk factors: Regulatory and compliance, Market acceptance, Market competition, Technology obsolescence, Labor/talent shortage/retention
- Current price 90.2% below estimated low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.22$, 4.33$]
- 2026-12-31 to 2027-12-31 estimated range: [0.80$, 2.81$]
Financial Metrics affecting the RBOT estimates:
- Negative: with PPE of -0.2 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: 49.86 < Shareholder equity ratio, % of 50.26 <= 58.56
- Positive: Interest expense per share per price, % of 0 <= 0
- Negative: negative Net income
- Positive: -51.61 < Industry operating profit margin (median), % of -29.60
- Positive: Industry inventory ratio change (median), % of 0.70 <= 1.15
Short-term RBOT quotes
Long-term RBOT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $80.67MM | $66.56MM | $50.97MM |
| Operating Income | $-80.67MM | $-66.56MM | $-50.97MM |
| Non-Operating Income | $9.60MM | $3.33MM | $0.79MM |
| Interest Expense | $0.03MM | $0.00MM | $0.00MM |
| R&D Expense | $47.58MM | $40.16MM | $33.60MM |
| Income(Loss) | $-71.07MM | $-63.22MM | $-50.18MM |
| Net Income(Loss)* | $-71.07MM | $-63.22MM | $-50.18MM |
| Stockholders Equity | $97.97MM | $46.70MM | $9.84MM |
| Assets | $119.86MM | $67.72MM | $19.58MM |
| Operating Cash Flow | $-62.30MM | $-49.96MM | $-45.08MM |
| Capital expenditure | $1.67MM | $0.18MM | $0.13MM |
| Investing Cash Flow | $-45.78MM | $6.86MM | $32.15MM |
| Financing Cash Flow | $44.70MM | $0.01MM | $5.76MM |
| Earnings Per Share** | $-14.70 | $-10.74 | $-8.45 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.